Rob studied Biochemistry at Cambridge University, then did his doctoral research with Prof. Ana Pombo at Imperial College and the Max Delbruck Centre in Berlin. Rob was then awarded a Sir Henry Wellcome Postdoctoral Fellowship to move to the MRC Weatherall Institute of Molecular Medicine and work with Prof. Doug Higgs on gene expression in early red blood cell differentiation. He joined the Wellcome Centre for Human Genetics as a new Group Leader in April 2022, supported by a Sir Henry Dale Fellowship from Wellcome and the Royal Society.
Rosa is a postdoctoral researcher working on Cornelia de Lange Syndrome (CdLS), which can be caused by mutations in NIPBL. Using a variety of molecular biology methods, such as Cut&Tag and GAM, she is investigating what happens to cells that make insufficient NIPBL due to mutations. Currently, she is focussing on heart development and trying to understand when and why heart defects occur in CdLS.
Previously, she completed her DPhil in the lab of Prof. Doug Higgs at the WIMM, working on CTCF and the importance of enhancer-promoter interactions for gene expression at the alpha-globin locus.
Ana studied Biotechnology at UCL and then did an MPhil in Genetics at Cambridge University. She is currently carrying out her PhD on cancer epigenetics under the supervision of Tom Milne and Rob Beagrie.
Ramy is a DPhil student in Adam Mead’s group investigating the effects of mutations in epigenetic regulators on the clonal evolution of haematopoietic stem cells in Myeloproliferative Neoplasms. He intends to utilise single-cell multi-omics techniques to discern phenotypic heterogeneities and elucidate mechanisms of fitness advantages in this rare cell population. The aim of this research is to potentially uncover targetable pathways or processes of interest that could help inform better patient treatment and future novel therapies.
Carol studied Systems Biology at Cambridge University, and is currently a Dphil student studying Interdisciplinary Biosciences DTP in partnership with Novo Nordisk. Her project centres around adipocyte development, enhancer biology and CRISPR technologies.